A systematic review and meta-analysis of clinician-reported versus patient-reported outcomes of radiation dermatitis.


Journal

Breast (Edinburgh, Scotland)
ISSN: 1532-3080
Titre abrégé: Breast
Pays: Netherlands
ID NLM: 9213011

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 10 07 2019
revised: 05 09 2019
accepted: 16 09 2019
pubmed: 30 9 2019
medline: 15 12 2020
entrez: 30 9 2019
Statut: ppublish

Résumé

Radiation dermatitis is a common adverse effect of radiotherapy (RT) in breast cancer patients. Although radiation dermatitis is reported by either the clinician or the patient, previous studies have shown disagreement between clinician-reported outcomes (CROs) and patient-reported outcomes (PROs). This review evaluated the extent of discordance between CROs and PROs for radiation dermatitis. Studies reporting both clinician and patient-reported outcomes for external beam RT were eligible. Nine studies met the inclusion criteria for the systematic review, while 8 of these studies were eligible for inclusion in a meta-analysis of acute and late skin toxicities. We found an overall agreement between CROs and PROs of acute skin colour change, fibrosis and/or retraction, and moist desquamation (p > 0.005). Reporting of late breast pain, breast edema, skin colour change, telangiectasia, fibrosis and/or retraction and induration/fibrosis alone (p > 0.005) were also in agreement between clinicians and patients. Our meta-analysis revealed a greater reporting of acute breast pain by patients (RR = 0.89, 95% CI 0.87-0.92, p < 0.001), greater reporting of acute breast edema by physicians (RR = 1.80, 95% CI 1.65-1.97, p < 0.001) and a greater reporting of late breast shrinkage by patients (RR = 0.61, 95% CI 0.44-0.86, p = 0.005). However, our review was limited by the discrepancies between PRO and CRO measurement tools as well as the absence of standard time points for evaluation of radiation dermatitis. Given potential discrepancies between CROs and PROs, both measures should be reported in future studies. Ultimately, we advocate for the development of a single tool to assess symptoms from both perspectives.

Identifiants

pubmed: 31563429
pii: S0960-9776(19)30558-2
doi: 10.1016/j.breast.2019.09.009
pmc: PMC7375608
pii:
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

125-134

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Références

J Pain Symptom Manage. 2016 Jun;51(6):1070-1090.e9
pubmed: 27112310
Haematologica. 2014 Apr;99(4):788-93
pubmed: 24241488
Sarcoma. 2016;2016:1014248
pubmed: 27725792
Clin Oncol (R Coll Radiol). 2016 Jun;28(6):354-64
pubmed: 27021931
Int J Radiat Oncol Biol Phys. 2011 Oct 1;81(2):397-402
pubmed: 20888137
Gastrointest Cancer Res. 2012 Jul;5(4):119-24
pubmed: 23077685
Ann Intern Med. 1993 Jul 15;119(2):121-6
pubmed: 8099769
Semin Radiat Oncol. 2003 Jul;13(3):176-81
pubmed: 12903007
Am J Clin Oncol. 2004 Dec;27(6):626-31
pubmed: 15577442
Radiother Oncol. 2018 Jan;126(1):163-169
pubmed: 28844787
Cancer. 2010 Aug 1;116(15):3549-57
pubmed: 20564138
Radiother Oncol. 2012 May;103(2):193-8
pubmed: 22521749
Cancer. 2006 Mar 1;106(5):991-9
pubmed: 16421922
Can Fam Physician. 2010 Dec;56(12):1277-84
pubmed: 21375063
JAMA Oncol. 2015 Oct;1(7):918-30
pubmed: 26247417
Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):839-44
pubmed: 22137022
BMJ. 2013 Jan 28;346:f167
pubmed: 23358487
South Med J. 2004 Oct;97(10):989-93
pubmed: 15558927
Oncol Nurs Forum. 2015 Sep;42(5):552-4
pubmed: 26302284
Int J Radiat Oncol Biol Phys. 2015 Jun 1;92(2):284-91
pubmed: 25754632
Clin Oncol (R Coll Radiol). 2016 Jun;28(6):345-353
pubmed: 26868286
Breast Cancer Res Treat. 2007 Nov;106(1):143-50
pubmed: 17221151
Ann Acad Med Singap. 1994 Mar;23(2):129-38
pubmed: 8080219
Radiother Oncol. 2019 May;134:220-230
pubmed: 31005219
J Oncol Pract. 2016 Feb;12(2):123-32
pubmed: 26869650
Ann Oncol. 2009 Dec;20(12):1929-35
pubmed: 19622510
Lancet Oncol. 2006 Nov;7(11):903-9
pubmed: 17081915
J Cutan Med Surg. 2001 Mar-Apr;5(2):105-10
pubmed: 11443481
Semin Oncol Nurs. 2011 May;27(2):e1-17
pubmed: 21514477
Cancer Nurs. 2013 Nov-Dec;36(6):E1-E16
pubmed: 23047799
Radiat Oncol J. 2017 Mar;35(1):32-38
pubmed: 28183159
Arch Intern Med. 2005 Jul 25;165(14):1574-80
pubmed: 16043674
Lancet. 2017 Sep 9;390(10099):1048-1060
pubmed: 28779963
Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):691-8
pubmed: 17011445
PLoS One. 2014 Oct 15;9(10):e110216
pubmed: 25333995

Auteurs

Emily Lam (E)

Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.

Caitlin Yee (C)

Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.

Gina Wong (G)

Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.

Marko Popovic (M)

Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.

Leah Drost (L)

Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.

Kucy Pon (K)

Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.

Danny Vesprini (D)

Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.

Henry Lam (H)

Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.

Saleh Aljabri (S)

Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.

Hany Soliman (H)

Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.

Carlo DeAngelis (C)

Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.

Edward Chow (E)

Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada. Electronic address: edward.chow@sunnybrook.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH